New schizophrenia treatments may be effective for subgroup of patients
Mounting evidence indicates that disturbances in the brain's glutamate pathway contribute to symptoms of schizophrenia. Thus, the glutamate pathway has become the target of a number of new drug therapies. Findings published ...
Dec 8, 2015
0
20